Thorne (Summerville, SC) announced it entered a definitive agreement to be acquired by The Procter & Gamble Company (P&G).

Since 1984, Thorne has been a leader in science-backed health solutions, serving consumers, athletes and health care professionals through rigorous world-class manufacturing and uncompromising quality. Thorne and P&G said that they share a belief that brands are built through a commitment to quality, innovation and earning consumer trust.

As per the acquisition, Thorne said that it will continue advancing its mission to become the world’s most trusted personalized health brand by helping consumers live healthier lives through science-backed solutions they can trust.

“For more than 40 years, Thorne has earned the trust of health care practitioners, consumers, and partners by putting science, quality, and the people we serve at the center of every decision,” said Colin Watts, CEO of Thorne. “As we looked to the future, we kept coming back to one question: What will best position Thorne to continue fulfilling its mission? We believe P&G is the right partner to help us expand our impact while staying true to the values and standards that have always defined Thorne.”

“This is an important step for P&G’s Personal Health Care business,” said Paul Gama, CEO of P&G Health Care. “Consumer interest in self-care, prevention, wellness, and personalized health continues to grow, and Thorne strengthens our position in premium wellness with a trusted, science-backed brand that complements our existing portfolio.”

The transaction is expected to close in 2026 subject to customary closing conditions and regulatory approvals. 

For more information, visit www.thorne.com or visit https://us.pg.com/.